COVID-19

The relationship between COVID-19’s severity and ischemic stroke: a systematic review and meta-analysis

Parkinson's disease may worsen outcomes from coronavirus disease 2019 (COVID-19) pneumonia in hospitalized patients: A systematic review, meta-analysis, and meta-regression

COVID-19 among patients with epilepsy: Risk factors and course of the disease

Ischemic Stroke, Inflammation, and Endotheliopathy in COVID-19 Patients

Cognitive impairment and altered cerebral glucose metabolism in the subacute stage of COVID-19

Neurological and cognitive sequelae of Covid-19: a four month follow-up

Factors associated with COVID-19 in people with Parkinson’s disease: a systematic review and meta-analysis

Encephalitis as Neurological Complication of COVID-19: A Systematic Review and Meta Analysis of Incidence, Outcomes and Predictors

Global Incidence of Neurological Manifestations Among Patients Hospitalized With COVID-19—A Report for the GCS-NeuroCOVID Consortium and the ENERGY Consortium

COVID-19 Among Patients With Multiple Sclerosis A Systematic Review

US Case Reports of Cerebral Venous Sinus Thrombosis With Thrombocytopenia After Ad26.COV2.S Vaccination, March 2 to April 21, 2021

Immunogenicity of COVID-19 mRNA Vaccines in Pregnant and Lactating Women

Characteristics and Outcomes Among US Patients Hospitalized for Ischemic Stroke Before vs During the COVID-19 Pandemic

Arterial events, venous thromboembolism, thrombocytopenia, and bleeding after vaccination with Oxford-AstraZeneca ChAdOx1-S in Denmark and Norway: population based cohort study

Public health impact of delaying second dose of BNT162b2 or mRNA-1273 covid-19 vaccine: simulation agent based modeling study